Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| GE HealthCare (GEHC) | Director | Jan 5, 2023 | May 11, 2026 |
| GE Aerospace (GE) | Chairman and CEO, Director | Apr 30, 2018 | Mar 4, 2026 |
| T. Rowe Price (TROW) | Former Director | Sep 11, 2015 | Apr 30, 2018 |
| Danaher Corporation (DHR) | Former President and CEO, Director | Aug 1, 2003 | Jul 22, 2014 |
Also a director at
GE Aerospace (GE), T. Rowe Price (TROW) (no filing in the last 18 months), Danaher Corporation (DHR) (no filing in the last 18 months)
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 7, 2026, GE HealthCare: 3,586 shares granted; 4,157 shares awarded. 1 filing: 1
- May 6, 2026, GE HealthCare: bought 80,805 shares for $5.0M (some held indirectly). 1 filing: 1
- Mar 3, 2026, GE Aerospace: 14,872 shares vested; 6,234 shares withheld by the company for taxes. 1 filing: 1
- Mar 1, 2026, GE Aerospace: 401,646 shares awarded; 169,539 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.